JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines

被引：0
|
作者：
P Nauroy
F Delhommeau
F Baklouti
机构：
[1] mRNA Metabolism in Normal and Pathological Cells,
[2] CNRS UMR 5534,undefined
[3] Université Lyon 1,undefined
[4] Sorbonne Universités,undefined
[5] UPMC Univ Paris 06,undefined
[6] GRC no. 07,undefined
[7] Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MyPAC,undefined
[8] AP-HP,undefined
[9] Hôpital Saint-Antoine,undefined
[10] Laboratoire d'Hématologie,undefined
[11] Sorbonne Universités,undefined
[12] UPMC Univ Paris 06,undefined
[13] UMR_S 938,undefined
[14] CDR Saint-Antoine,undefined
[15] INSERM,undefined
[16] UMR_S 938,undefined
[17] CDR Saint-Antoine,undefined
[18] Current address: Institut de Génomique Fonctionnelle de Lyon,undefined
[19] Ecole Normale Supérieure,undefined
[20] Lyon,undefined
[21] France,undefined
来源：
Blood Cancer Journal | 2014年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：e222 / e222
相关论文
共 50 条
  • [1] JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
    Nauroy, P.
    Delhommeau, F.
    Baklouti, F.
    BLOOD CANCER JOURNAL, 2014, 4 : e222 - e222
  • [2] Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm
    Peyro-Saint-Paul, Helene
    Hermitte, Fabienne
    BLOOD, 2010, 116 (11) : 1994 - 1995
  • [3] Prevalence of JAK2V617F, CALR in Philadelphia Positive and Negative Myeloproliferative Neoplasm
    Abedi, Elham
    Karimi, Mehran
    Cohan, Nader
    Haghpanah, Sezaneh
    Yaghobi, Ramin
    Azarpira, Negar
    Moghadam, Mohamad
    Bayat, Elahe
    Farokhian, Farnoush
    Mohammadi, Hamid
    Lak, Elahe Razmara
    Golafshan, Habib Allah
    Ramzi, Mani
    GALEN MEDICAL JOURNAL, 2021, 10
  • [4] A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
    C Marty
    C Lacout
    N Droin
    J-P Le Couédic
    V Ribrag
    E Solary
    W Vainchenker
    J-L Villeval
    I Plo
    Leukemia, 2013, 27 : 2187 - 2195
  • [5] A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
    Marty, C.
    Lacout, C.
    Droin, N.
    Le Couedic, J-P
    Ribrag, V.
    Solary, E.
    Vainchenker, W.
    Villeval, J-L
    Plo, I.
    LEUKEMIA, 2013, 27 (11) : 2187 - 2195
  • [6] Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha.
    Lane, Steven W.
    Mullally, Ann
    ONCOTARGET, 2013, 4 (04) : 500 - 501
  • [7] Jak2V617F Reversible Activation Shows an Essential Requirement for Jak2V617F in Myeloproliferative Neoplasms (MPNs)
    Dunbar, Andrew
    Bowman, Robert L.
    Park, Young
    Izzo, Franco
    Myers, Robert M.
    Karzai, Abdul
    Kim, Won Jun
    Maestre, Ines Fernandez
    Waarts, Michael R.
    Nazir, Abbas
    Xiao, Wenbin
    Brodsky, Max
    Farina, Mirko
    Cai, Louise
    Cai, Sheng F.
    Wang, Benjamin
    An, Wenbin
    Yang, Julie
    Mowla, Shoron
    Eisman, Shira E.
    Mishra, Tanmay
    Houston, Remie
    Guzzardi, Emily
    Benitez, Anthony R. Martinez
    Viny, Aaron D.
    Koche, Richard
    Landau, Dan A.
    Levine, Ross L.
    BLOOD, 2022, 140
  • [8] Correlative study between the JAK2V617F mutation and thrombosis in patients with myeloproliferative neoplasm
    Li, Z. C.
    Fu, H. J.
    Wang, Z. M.
    Yang, S.
    Xu, H. Z.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (03):
  • [9] Discussion of the correlation between JAK2V617f mutation and thromboembolism in myeloproliferative neoplasm patients
    Xia, L.
    Wu, J-S
    Ding, K-Y
    Zeng, Q-S
    Cai, X-Y
    Zhu, W-B
    Wu, L-L
    Liu, X.
    Yang, H-Z
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 635 - 636
  • [10] Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
    Marty, Caroline
    Lacout, Catherine
    Martin, Antoine
    Hasan, Salma
    Jacquot, Sylvie
    Birling, Marie-Christine
    Vainchenker, William
    Villeval, Jean-Luc
    BLOOD, 2010, 116 (05) : 783 - 787
12345